Skip to content
healthcare.dev

BENDAMUSTINE HYDROCHLORIDE

NDC 83831-183, bendamustine hydrochloride, injection, from Avyxa Pharma, LLC.

Product NDC
83831-183
Status
Listed
Labeler
Avyxa Pharma, LLC
Dosage form
INJECTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA219014
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/83831-183 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BENDAMUSTINE HYDROCHLORIDE100 mg/4mL

Pharmacologic classes

Alkylating Activity [MoA]; Alkylating Drug [EPC]

Package NDCNDC-11Package
83831-183-04838310183041 VIAL in 1 CARTON (83831-183-04) / 4 mL in 1 VIAL

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/f359e7c6-d104-457d-a7fe-597c74440353

Use it

Look up 83831-183 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/83831-183 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 83831-183. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.